Immunization, Vaccines and Biologicals

Newsroom

9 January 2015

PATH/G. Bienczycki

WHO has opened the door to routine immunization of infants in Africa by approving for use an innovative and affordable vaccine that has all but rid the meningitis belt of a major cause of deadly epidemics.

Since its introduction in Africa in December 2010, MenAfriVac has had an immediate and dramatic impact in breaking the cycle of meningitis A epidemics, leading the safe, effective technology to be approved by WHO through its prequalification process for use in infants, and paving the way for protecting millions more children at risk of the deadly disease.

Fact sheets

Fact sheets on vaccines and immunization

Millennium Development Goals

Immunization's contribution to reaching the Millennium Development Goal on child survival

News archive

Immunization newsroom stories featured over the last five years

Immunization highlights

An overview of key achievements by WHO and partners in the area of immunization. Now published annually

Events

Calendar of key immunization events and features on vaccine and report launches, exhibits and advocacy efforts

Communication products

Key resources and other documentation pertinent to our immunization work